AMD Ticking higher on unconfirmed takeover chatter

MSFT rumored as a potential acquirer in the high $ teens Related ( MSFT )


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/AMD/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/AMD/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: MSFT rumored as a potential acquirer in the high $ teens Related ( MSFT ) - Source TradeTheNews.com

Time: Wednesday, March 07, 2018 10:28

Intraday Maximum Change: $0.885 - 6.947% Minutes After: 19


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-11.855 - -INF% Days Since: 753

Snapshot of company's key stats at the time of the event

Market Cap: 11,338,841,335 Shares Outstanding: 969,131,738 Float: 956,744,357

Day's Short Interest: 159,550,221 Short Ratio: 2.51%

Institutional Ownership: 54% Insider Ownership: 1.3%

AMD -

Sector: - Industry:

EVHC UnitedHealth reportedly among bidders for Envision healthcare division

** NOTE: 02/08 EVHC Reportedly has commenced a sale process
– M&A blog- 01/04 EVHC Hires advisors to consider strategic alternatives Related ( UNH )


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/EVHC/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/EVHC/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: EVHC UnitedHealth reportedly among bidders for Envision healthcare division - press - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 15:27

Intraday Maximum Change: $0.97 - 2.314% Minutes After: 6


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-40.94 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 5,174,423,155 Shares Outstanding: 120,925,991 Float: 119,317,183

Day's Short Interest: 24,236,161 Short Ratio: 10.06%

Institutional Ownership: 75.7% Insider Ownership: 1.3%

EVHC -

Sector: - Industry:

QCOM Qualcomm and Huawai reportedly may come to resolution on patent royalty lawsuit soon


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/QCOM/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/QCOM/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: QCOM Qualcomm and Huawai reportedly may come to resolution on patent royalty lawsuit soon - press - (related NXPI HUAWEI.CN) - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 14:56

Intraday Maximum Change: $0.44 - 0.7072% Minutes After: 54


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-61.78 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 91,516,059,082 Shares Outstanding: 1,480,363,298 Float: 1,478,807,883

Day's Short Interest: 20,160,303 Short Ratio: 1.19%

Institutional Ownership: 47.4% Insider Ownership: 0.1%

QCOM -

Sector: - Industry:

ABT FDA expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects

Specifically, the agency approved the Masters Series Mechanical Heart Valve with Hemodynamic Plus (HP) Sewing Cuff to include the 15-mm valve size, making it the smallest mechanical heart valve approved in the world.

The Masters Series Mechanical Heart Valve was first approved in 1995 for patients with a diseased, damaged or malfunctioning aortic or mitral heart valve. The device is also approved for use in replacing previously implanted aortic or mitral prosthetic heart valves. Today’s approval expands the range of valve sizes available, providing smaller patients another treatment option.

The FDA evaluated clinical data from a single-arm study of 20 pediatric patients with serious heart failure ranging in age from 1.5 weeks to 27 months at the time of mitral valve implant.

The data showed that one year after the implant procedure, the probability of survival was 69.3 percent and the probability of not experiencing a valve-related adverse event was 66.8 percent. Serious valve-related adverse events observed during the study through one-year follow-up included blood clots in the device and bleeding in the brain. Anticoagulation (blood thinning) therapy may be necessary after the procedure, to prevent clotting on the device, which can increase the risk of bleeding.

The FDA granted approval of the Master Series Heart Valve to St. Jude Medical. – Source TradeTheNews.com


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/ABT/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/ABT/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: ABT FDA expanded the approval of a heart valve to include a size small enough to be used in newborn pediatric patients to treat heart defects - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 13:58

Intraday Maximum Change: $0.705 - 1.156% Minutes After: 61


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-60.285 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 111,066,835,531 Shares Outstanding: 1,746,333,892 Float: 1,732,649,487

Day's Short Interest: 11,910,880 Short Ratio: 1.59%

Institutional Ownership: 46.3% Insider Ownership: 0.8%

ABT -

Sector: - Industry:

LJPC Giapreza (angiotensin II) significantly improved survival and reduced time on renal replacement therapy in patients with acute kidney injury

Giapreza (angiotensin II) significantly improved survival and reduced time on renal replacement therapy in patients with acute kidney injury.

– Announced the release of data from analyses of the impact of GIAPREZA (angiotensin II) on outcomes of a subset of patients with acute kidney injury requiring renal replacement therapy (AKI-RRT) enrolled in the ATHOS-3 (Angiotensin II for the Treatment of High Output Shock) study.

– The presentation, entitled “Outcomes in Patients with Acute Kidney Injury Receiving Angiotensin II for Vasodilatory Shock,” will take place during The 23rd International Conference on Advances in Critical Care Nephrology – AKI & CRRT 2018, being held March 6-9, 2018 in San Diego, California. The manuscript, entitled “Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II” was published online in Critical Care Medicine.“Acute kidney injury requiring dialysis associated with distributive shock, also referred to as vasodilatory shock, represents a significant medical risk for patients and a significant financial burden to the health care system,” said James Tumlin M.D., Professor of Medicine and Director of NephroNet Clinical Trials Consortium. “These analyses of the effect of angiotensin II on AKI patients requiring dialysis in the ATHOS-3 study demonstrated angiotensin II is a promising therapy to address this unmet need.”

– The presentations and manuscript detail the outcomes of patients with acute kidney injury (AKI) and vasodilatory shock enrolled in the ATHOS-3 study of GIAPREZA. In this post-hoc analysis, the data from 105 AKI patients (GIAPREZA n=45; placebo n=60) requiring renal replacement therapy (RRT) at study drug initiation were analyzed. Survival through day 28 was 53% (95% CI: 38%-67%) for the GIAPREZA group compared to 30% (95% CI: 19%-41%) for the placebo group (p = 0.012). By day 7, 38% (95% CI: 25%-54%) of patients treated with GIAPREZA discontinued RRT compared to 15% (95% CI: 8%-27%) of patients treated with placebo (p = 0.007). Mean arterial pressure (MAP) response at hour 3 was achieved in 53% (95% CI: 38%-68%) of patients treated with GIAPREZA compared to 22% (95% CI: 12%-34%) of patients treated with placebo (p = 0.001). – Source TradeTheNews.com


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/LJPC/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/LJPC/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: LJPC Giapreza (angiotensin II) significantly improved survival and reduced time on renal replacement therapy in patients with acute kidney injury - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 14:39

Intraday Maximum Change: $0.79 - 2.49% Minutes After: 72


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-30.94 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 722,463,007 Shares Outstanding: 22,168,242 Float: 20,503,195

Day's Short Interest: 6,497,946 Short Ratio: 10.82%

Institutional Ownership: 77.7% Insider Ownership: 7.5%

LJPC -

Sector: - Industry:

OSTK Ticks higher as Passport Capital says Overstock is largest holding in its dedicated cryptocurrency fund


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/OSTK/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/OSTK/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: OSTK Ticks higher as Passport Capital says Overstock is largest holding in its dedicated cryptocurrency fund - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 13:29

Intraday Maximum Change: $-1.445 - -2.377% Minutes After: 48


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-62.225 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 1,812,341,734 Shares Outstanding: 28,744,516 Float: 26,843,582

Day's Short Interest: 7,081,711 Short Ratio: 1.99%

Institutional Ownership: 46.2% Insider Ownership: 6.6%

OSTK -

Sector: - Industry:

MDLZ Spokesperson: confirms cancelled from UBS conference due to executive illness


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/MDLZ/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/MDLZ/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: Spokesperson: confirms cancelled from UBS conference due to executive illness - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 14:13

Notes: 03/0613:22MDLZ Hearing chatter circulating that Mondelez cancelled out of UBS conference Follow up: executive illness cited - Source TradeTheNews.com

Intraday Maximum Change: $-0.265 - -0.5842% Minutes After: 2


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-45.625 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 65,442,452,504 Shares Outstanding: 1,487,328,466 Float: 1,477,602,811

Day's Short Interest: 16,727,298 Short Ratio: 1.6%

Institutional Ownership: 45.4% Insider Ownership: 0.7%

MDLZ -

Sector: - Industry:

WBAI Entered into framework agreement with the China Sports Lottery Administration Center to develop physical sales channels


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/WBAI/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/WBAI/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: 09:50 WBAI Entered into framework agreement with the China Sports Lottery Administration Center to develop physical sales channels - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 10:08

Notes: - Company and the China Sports Lottery Administration Center (the "Sports Lottery Center") entered into a framework agreement (the "Framework Agreement") today, under which both parties plan to cooperate to develop physical channels to sell sports lottery tickets (the "Project"). - Under the Framework Agreement, the Sports Lottery Center will provide support to the Project. In the meantime, the Company will seek to enter into cooperation agreements with provincial (including regional and municipal) sports lotteries centers to assist in installing sports lottery terminals and provide relevant maintenance and operational services in accordance with local development plans for sports lottery business and requests of such provincial (including regional and municipal) sports lotteries centers, in order to enhance the convenience of sports lottery ticket purchases, enlarge customer base and optimize user experience for lottery purchasers. - The Sports Lottery Center is the sports lottery issuance agency established by the General Administration of Sports in accordance with relevant laws, and it is the government authority in charge of the issuance and organizing sales of sports lottery products in China. - Source TradeTheNews.com

Intraday Maximum Change: $3.1 - 13.61% Minutes After: 15


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-19.68 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 788,764,864 Shares Outstanding: 40,805,218 Float: 40,805,218

Day's Short Interest: 4,056,807 Short Ratio: 14.08%

Institutional Ownership: 0% Insider Ownership: 0%

WBAI -

Sector: - Industry:

ON Hearing takeover chatter circulating


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/ON/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/ON/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: ON Hearing takeover chatter circulating- Intel rumored as potential acquirer, price chatter in low $30s - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 10:40

Intraday Maximum Change: $0.8 - 3.11% Minutes After: 171


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-24.92 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 11,086,984,095 Shares Outstanding: 425,440,679 Float: 415,274,007

Day's Short Interest: 19,107,874 Short Ratio: 2.38%

Institutional Ownership: 63.9% Insider Ownership: 2.4%

ON -

Sector: - Industry:

UAA Hearing Hedgeye adds to best idea short list


Warning: file_get_contents(https://api.iextrading.com/1.0/stock/UAA/company): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 402

Warning: file_get_contents(https://api.iextrading.com/1.0/stock/UAA/quote): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 406

News: Hearing Hedgeye adds to best idea short list - Source TradeTheNews.com

Time: Tuesday, March 06, 2018 10:04

Intraday Maximum Change: $-0.295 - -1.714% Minutes After: 10


Warning: Division by zero in /home/n00bis5/public_html/alphadiz/wp/wp-content/themes/twentyseventeen-child/template-parts/post/content.php on line 449

Latest Quote: Change Since: $-17.505 - -INF% Days Since: 754

Snapshot of company's key stats at the time of the event

Market Cap: 7,587,681,576 Shares Outstanding: 442,172,586 Float: 405,463,134

Day's Short Interest: 58,395,812 Short Ratio: 5.96%

Institutional Ownership: 19.7% Insider Ownership: 8.3%

UAA -

Sector: - Industry: